Paramount Bio-Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-01-2025
- Paid Up Capital ₹ 0.20 M
as on 01-01-2025
- Company Age 14 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.59 Cr
as on 01-01-2025
- Revenue 58.19%
(FY 2021)
- Profit 74.62%
(FY 2021)
- Ebitda 71.63%
(FY 2021)
- Net Worth 137.00%
(FY 2021)
- Total Assets 19.16%
(FY 2021)
About Paramount Bio-Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹14.59 Cr.
Prakash Chaudhari, Sachin Chaudhari, and Umesh Choudhary serve as directors at the Company.
- CIN/LLPIN
U24210MP2010PTC025069
- Company No.
025069
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Paramount Bio-Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Chaudhari  | Director | 14-Aug-2018 | Current |
| Sachin Chaudhari | Director | 14-Aug-2018 | Current |
| Umesh Choudhary | Director | 06-Aug-2019 | Current |
Financial Performance of Paramount Bio-Science.
Paramount Bio-Science Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 58.19% increase. The company also saw a substantial improvement in profitability, with a 74.62% increase in profit. The company's net worth Soared by an impressive increase of 137%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paramount Bio-Science?
In 2021, Paramount Bio-Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mexican Fertilizer & Chemicals Private LimitedActive 11 years 8 monthsPrakash Chaudhari and Sachin Chaudhari are mutual person
Jordann Phosphate Private LimitedActive 4 years 2 monthsPrakash Chaudhari and Sachin Chaudhari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Jun 2021 | ₹6.65 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Jun 2021 | ₹7.94 Cr | Open |
How Many Employees Work at Paramount Bio-Science?
Unlock and access historical data on people associated with Paramount Bio-Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paramount Bio-Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paramount Bio-Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
